ClinicalTrials.Veeva

Menu

VITAMIN D METABOLITES AS BIOMARKERS FOR THE IDENTIFICATION OF KIDNEY INJURY IN CARDIAC SURGERY (VITAL)

University Health Network, Toronto logo

University Health Network, Toronto

Status

Not yet enrolling

Conditions

Chronic Renal Diseases
Acute Kidney Injuries

Study type

Observational

Funder types

Other

Identifiers

NCT06688994
23-6027

Details and patient eligibility

About

We will be measuring vitamin D metabolites in blood samples drawn from patients undergoing cardiac surgery to determine the correlation with renal function as assessed by serum creatinine. We will include 20 patients in each of the following 3 groups based on serum creatinine measured within 28-days of surgery: 1) normal kidney function (eGFR > 60 mL/min, n=20), 2) moderate impaired kidney function, eGFR between 30 and 60 mL/min (n=20) and 3) severe kidney dysfunction eGFR < 30 mL/min (n=20).

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • ≥ 18 years
  • Patients undergoing cardiac surgery
  • Serum Creatinine measured with 28 days of surgery

Exclusion Criteria

  • Exogeneous calcitriol (1,25(OH)2D3) intake
  • History of parathyroidectomy
  • Patients with liver or kidney cancer
  • Patients with liver disease (e.g. liver failure, cirrhosis)

Trial contacts and locations

1

Loading...

Central trial contact

Stuart A McCluskey, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems